CVE-2026-15415
Received
Received - Intake
Path Traversal in AWS HealthOmics MCP Server
Vulnerability report for CVE-2026-15415, including description, CVSS score, EPSS score, affected products, exploitability, helpful resources, and attack-flow context.
Publication date: 2026-07-17
Last updated on: 2026-07-17
Assigner: AMZN
Description
Description
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research.
Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input.
To remediate this issue, users should upgrade to version 0.0.36 or later.
CVSS Scores
EPSS Scores
| Probability: | |
| Percentile: |
Meta Information
Affected Vendors & Products
| Vendor | Product | Version / Range |
|---|---|---|
| aws | aws_healthomics_mcp_server | 0.0.36 |
| aws | aws-healthomics-mcp-server | to 0.0.36 (exc) |
Helpful Resources
Exploitability
| CWE ID | Description |
|---|---|
| CWE-23 | The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize sequences such as ".." that can resolve to a location that is outside of that directory. |